AIDS News and Research

RSS

New QCovid tool helps identify vaccinated groups at highest risk of Covid-19 hospitalization and death

Researchers from the University of Oxford have today reported on findings on the vaccinated people who are at greatest risk from severe Covid-19 leading to hospitalization or death from 14 days post the second dose vaccination, when substantial immunity should be expected.

20 Sep 2021

A 100% French nasal vaccine against SARS-CoV-2 to move into the clinical phase in 2022

In contrast to intramuscular vaccines, only nasal vaccines are able to block the virus in the nose by inducing local immunity in the nasal mucosa, i.e. the portal of entry and multiplication of the virus.

18 Sep 2021

Grants to promote COVID-19 vaccination among people with intellectual and developmental disabilities

Patients with intellectual and developmental disabilities (IDD) are three times more likely to die from COVID-19 than the general population. Their heightened risk is due to a variety of causes: pre-existing health conditions, such as respiratory problems or obesity; increased likelihood of living in group homes, taking shared transportation, and being exposed to people outside their households; and struggles with safety precautions like mask-wearing or social distancing.

16 Sep 2021

Albert Einstein College of Medicine receives $5 million NIH grant for IDD research

Albert Einstein College of Medicine has received a five-year, $5 million grant from the National Institutes of Health to support the Rose F. Kennedy Intellectual and Developmental Disabilities Research Center, which has been at the forefront of research on normal and abnormal brain development for more than 50 years.

15 Sep 2021

Over half of states have rolled back public health powers in pandemic

Republican legislators in more than half of U.S. states, spurred on by voters angry about lockdowns and mask mandates, are taking away the powers state and local officials use to protect the public against infectious diseases.

15 Sep 2021

Functional impairment of HIV-specific T cells precedes aborted virus control

HIV is a master of evading the immune system, using a variety of methods to prevent the body from being able to find and kill it.

13 Sep 2021

Microscopy paired with AI leads to a fast, accurate, and cost-effective COVID-19 test

Beckman researchers paired microscopy with artificial intelligence to develop a COVID-19 test that's fast, accurate, and cost-effective. All we need to do is say "ahh."

12 Sep 2021

People with Parkinson's may benefit from seven categories of compensation strategies

Various strategies can help people with Parkinson's who have difficulty walking, but a new study finds that many people have never heard of or tried these strategies.

9 Sep 2021

Younger children more vulnerable to chemotherapy-related hearing loss, study finds

A chemotherapy drug known to cause hearing loss in children is more likely to do so the earlier in life children receive it, new UBC research has found.

7 Sep 2021

Research reveals the impact of nicotine-containing e-cigarettes on the body

Using e-cigarettes containing nicotine causes an immediate increase in the formation of blood clots and a deterioration in the ability of small blood vessels to expand and dilate, as well as raised heart rate and blood pressure, according to research presented at the European Respiratory Society International Congress.

6 Sep 2021

Study finds SARS-CoV-2 affects the brain by binding with MAO enzymes

A new study by researchers in Croatia and Slovenia shows the SARS-CoV-2 spike protein has an affinity towards monoamine oxidases (MAO) enzymes. Changes in MAO levels have been the culprit for several neuropsychiatric disorders such as Parkinson’s or Alzheimer’s disease.

6 Sep 2021

Efficacy of vaccines against the SARS-CoV-2 Delta variant

A new study uses statistical models to determine vaccine efficacy against the various SARS-CoV-2 variants and clinical endpoints for SARS-CoV-2 variants.

5 Sep 2021

HIV vaccine candidate trialed in Sub-Saharan Africa falls short

An HIV vaccine candidate trialed in Sub-Saharan Africa offers no substantial protection against HIV infection among young women, the study organizers say.

4 Sep 2021

New computational approach may predict how individuals are likely to respond to vaccines

In an advance that sheds light on why certain vaccines may influence people differently, a new computational approach developed at the University of Michigan may predict how individual patients are likely to respond.

2 Sep 2021

New digital solution for people living with severe mental illnesses

The pandemic has made it more difficult for the 430,000+ Australians living with severe mental illnesses who are highly vulnerable to acute illness relapses when their habitual routines and standard health care arrangements are disrupted.

2 Sep 2021

Research investigates how drug-eluting stent affects arterial tissue permeability and blood flow

For patients with symptomatic coronary artery disease, the best course of action often involves implanting a drug-eluting stent into the artery where a plaque buildup is blocking blood flow to the heart.

2 Sep 2021

Experts show waning effectiveness of COVID-19 vaccines over time

In a letter to The New England Journal of Medicine, publishing online September 1, 2021, an interdisciplinary team of physicians and public health experts at University of California San Diego measured the effectiveness of COVID-19 mRNA vaccines among health workers at UC San Diego Health, most notably during the emergence of the highly transmissible delta virus variant and coincident with the end of the state's mask mandate, allowing fully vaccinated persons to forgo face coverings in most places.

1 Sep 2021

New trial to assist patients with severe and enduring mental health illnesses

1 Sep 2021

Post mRNA-1273 vaccination rashes

A group of researchers reported that skin reactions after the administration of the mRNA-1273 vaccine are rare yet possible.

30 Aug 2021

ACTG announces positive data for monoclonal antibody combination therapy from the ACTIV-2 study

The AIDS Clinical Trials Group, the largest global HIV research network, which has expanded its focus to include evaluating outpatient treatment for COVID-19, today announced positive data for the monoclonal antibody combination therapy BRII-196/BRII-198 from the ACTIV-2 study of Outpatient Monoclonal Antibodies and Other Therapies.

27 Aug 2021

AIDS News and Research

New QCovid tool helps identify vaccinated groups at highest risk of Covid-19 hospitalization and death

A 100% French nasal vaccine against SARS-CoV-2 to move into the clinical phase in 2022

Grants to promote COVID-19 vaccination among people with intellectual and developmental disabilities

Albert Einstein College of Medicine receives $5 million NIH grant for IDD research

Over half of states have rolled back public health powers in pandemic

Functional impairment of HIV-specific T cells precedes aborted virus control

Microscopy paired with AI leads to a fast, accurate, and cost-effective COVID-19 test

People with Parkinson's may benefit from seven categories of compensation strategies

Younger children more vulnerable to chemotherapy-related hearing loss, study finds

Research reveals the impact of nicotine-containing e-cigarettes on the body

Study finds SARS-CoV-2 affects the brain by binding with MAO enzymes

Efficacy of vaccines against the SARS-CoV-2 Delta variant

HIV vaccine candidate trialed in Sub-Saharan Africa falls short

New computational approach may predict how individuals are likely to respond to vaccines

New digital solution for people living with severe mental illnesses

Research investigates how drug-eluting stent affects arterial tissue permeability and blood flow

Experts show waning effectiveness of COVID-19 vaccines over time

New trial to assist patients with severe and enduring mental health illnesses

Post mRNA-1273 vaccination rashes

ACTG announces positive data for monoclonal antibody combination therapy from the ACTIV-2 study

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News